Effect of Rivaroxaban on thrombin generation in vivo. A study in obese patients

被引:17
作者
Bertaggia-Calderara, D. [1 ,2 ,3 ]
Kroll, D. [4 ]
Gerschheimer, C. [1 ,2 ,3 ]
Nicolas, N. [1 ,2 ,3 ]
Nett, P. [4 ]
Stirnimann, G. [4 ]
Alberio, L. [1 ,2 ,3 ]
机构
[1] Lausanne Univ Hosp, CHUV, Div Hematol, Lausanne, Switzerland
[2] Lausanne Univ Hosp, CHUV, Cent Hematol Lab, Lausanne, Switzerland
[3] Univ Lausanne, Lausanne, Switzerland
[4] Bern Univ Hosp, Dept Visceral Surg & Med, Inselspital, Bern, Switzerland
关键词
FACTOR-XA INHIBITOR; VENOUS THROMBOEMBOLISM; IN-VITRO; PHARMACODYNAMICS; PHARMACOKINETICS; REPLACEMENT; ACTIVATION; WARFARIN; SURGERY; IMPACT;
D O I
10.1111/ijlh.12767
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E11 / E14
页数:4
相关论文
共 12 条
  • [11] In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939 -: an oral, direct Factor Xa inhibitor
    Perzborn, E
    Strassburger, J
    Wilmen, A
    Pohlmann, J
    Roehrig, S
    Schlemmer, KH
    Straub, A
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (03) : 514 - 521
  • [12] Assessment of laboratory assays to measure rivaroxaban - an oral, direct factor Xa inhibitor
    Samama, Meyer Michel
    Martinoli, Jean-Luc
    LeFlem, Lena
    Guinet, Celine
    Plu-Bureau, Genevieve
    Depasse, Francois
    Perzborn, Elisabeth
    [J]. THROMBOSIS AND HAEMOSTASIS, 2010, 103 (04) : 815 - 825